Literature DB >> 15363640

Role of carnitine esters in brain neuropathology.

Ashraf Virmani1, Zbigniew Binienda.   

Abstract

L-Carnitine (L-C) is a naturally occurring quaternary ammonium compound endogenous in all mammalian species and is a vital cofactor for the mitochondrial oxidation of fatty acids. Fatty acids are utilized as an energy substrate in all tissues, and although glucose is the main energetic substrate in adult brain, fatty acids have also been shown to be utilized by brain as an energy substrate. L-C also participates in the control of the mitochondrial acyl-CoA/CoA ratio, peroxisomal oxidation of fatty acids, and the production of ketone bodies. Due to their intrinsic interaction with the bioenergetic processes, they play an important role in diseases associated with metabolic compromise, especially mitochondrial-related disorders. A deficiency of carnitine is known to have major deleterious effects on the CNS. Several syndromes of secondary carnitine deficiency have been described that may result from defects in intermediary metabolism and alterations principally involving mitochondrial oxidative pathways. Mitochondrial superoxide formation resulting from disturbed electron transfer within the respiratory chain may affect the activities of respiratory chain complexes I, II, III, IV, and V and underlie some CNS pathologies. This mitochondrial dysfunction may be ameliorated by L-C and its esters. In addition to its metabolic role, L-C and its esters such as acetyl-L-carnitine (ALC) poses unique neuroprotective, neuromodulatory, and neurotrophic properties which may play an important role in counteracting various disease processes. Neural dysfunction and metabolic imbalances underlie many diseases, and the inclusion of metabolic modifiers may provide an alternative and early intervention approach, which may limit further developmental damage, cognitive loss, and improve long-term therapeutic outcomes. The neurophysiological and neuroprotective actions of L-C and ALC on cellular processes in the central and peripheral nervous system show such effects. Indeed, many studies have shown improvement in processes, such as memory and learning, and are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363640     DOI: 10.1016/j.mam.2004.06.003

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  42 in total

1.  Acetyl-L-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury.

Authors:  Samir P Patel; Patrick G Sullivan; Travis S Lyttle; Alexander G Rabchevsky
Journal:  J Neurochem       Date:  2010-04-23       Impact factor: 5.372

2.  Acetyl-L-carnitine increases mitochondrial protein acetylation in the aged rat heart.

Authors:  Janos Kerner; Elizabeth Yohannes; Kwangwon Lee; Ashraf Virmani; Aleardo Koverech; Claudio Cavazza; Mark R Chance; Charles Hoppel
Journal:  Mech Ageing Dev       Date:  2015-02-07       Impact factor: 5.432

3.  Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.

Authors:  Haiyan Fu; Aaron S Meadows; Tierra Ware; Robert P Mohney; Douglas M McCarty
Journal:  Mol Ther       Date:  2017-01-28       Impact factor: 11.454

4.  Metabolism of acetyl-L-carnitine for energy and neurotransmitter synthesis in the immature rat brain.

Authors:  Susanna Scafidi; Gary Fiskum; Steven L Lindauer; Penelope Bamford; Da Shi; Irene Hopkins; Mary C McKenna
Journal:  J Neurochem       Date:  2010-05-13       Impact factor: 5.372

5.  Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: a randomized and controlled clinical trial.

Authors:  Michele Malaguarnera; Marco Vacante; Massimo Motta; Maria Giordano; Giulia Malaguarnera; Rita Bella; Giuseppe Nunnari; Liborio Rampello; Giovanni Pennisi
Journal:  Metab Brain Dis       Date:  2011-08-26       Impact factor: 3.584

6.  The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.

Authors:  Ashraf Virmani; Luigi Pinto; Otto Bauermann; Saf Zerelli; Andreas Diedenhofen; Zbigniew K Binienda; Syed F Ali; Feike R van der Leij
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

7.  Acetyl-L-carnitine treatment following spinal cord injury improves mitochondrial function correlated with remarkable tissue sparing and functional recovery.

Authors:  S P Patel; P G Sullivan; T S Lyttle; D S K Magnuson; A G Rabchevsky
Journal:  Neuroscience       Date:  2012-03-15       Impact factor: 3.590

8.  Biochemical and genetic alterations of oxidant/antioxidant status of the brain in rats treated with dexamethasone: protective roles of melatonin and acetyl-L-carnitine.

Authors:  Naglaa Assaf; Aziza B Shalby; Wagdy K B Khalil; Hanaa H Ahmed
Journal:  J Physiol Biochem       Date:  2011-10-11       Impact factor: 4.158

9.  L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.

Authors:  Angela Sitta; Alethéa G Barschak; Marion Deon; Jurema F de Mari; Amanda T Barden; Camila S Vanzin; Giovana B Biancini; Ida V D Schwartz; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2008-09-24       Impact factor: 5.046

10.  Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.

Authors:  Mariano Malaguarnera; Maria Pia Gargante; Erika Cristaldi; Marco Vacante; Corrado Risino; Lisa Cammalleri; Giovanni Pennisi; Liborio Rampello
Journal:  Dig Dis Sci       Date:  2008-03-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.